SiTime to Present at the Raymond James TMT and Consumer Conference on December 10
SiTime Corporation Presentation: SiTime will present at the Raymond James TMT and Consumer Conference on December 10, 2024, with a fireside chat scheduled for 10:00 a.m. EST and meetings with investors throughout the day.
Company Overview: SiTime is a leading Precision Timing company specializing in semiconductor MEMS programmable solutions, having shipped over 3 billion devices and aiming to enhance product performance and reliability.
Trade with 70% Backtested Accuracy
Analyst Views on SITM
About SITM
About the author

New Additions to S&P 500: Vertiv Holdings, Lumentum Holdings, Coherent, and Echosstar are set to join the S&P 500 index.
Market Impact: The inclusion of these companies may influence market dynamics and investor strategies as they become part of a major stock index.

New Additions to S&P 500: Vert Holdings, Lumentum Holdings, CohereNT, and EchoStar are set to join the S&P 500 index.
Other Index Changes: Additional companies will be added to the S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices.
Index Changes: S&P Dow Jones Indices is making significant adjustments to its major stock indexes this month.
New Additions: The changes include the addition of several technology and infrastructure companies.
Removals: Some well-known companies are being removed from the indexes as part of this reshuffling.
Market Impact: These adjustments may influence market dynamics and investor strategies moving forward.
- Potential BDx Sale: I Squared Capital is considering options for its Asian data center business BDx, with a potential sale price of up to $2 billion, which could reshape its investment portfolio in the Asian market.
- Four Roses Brand Deal: Kirin Holdings has agreed to sell the Four Roses bourbon brand to E. & J. Gallo Winery for approximately $775 million (around 120 billion yen), enhancing Gallo's position in the premium spirits market.
- Genius Sports Acquisition: Genius Sports has agreed to acquire digital sports and gambling media company Legend for $1.2 billion, with $900 million in cash and $100 million in stock, financed through an $850 million loan, despite a 27% drop in stock price following the announcement.
- Bankruptcy Filing Preparation: Catalyst Brands is preparing to file for bankruptcy for the entity operating Eddie Bauer locations, which may impact the overall operations and brand value of Authentic Brands Group.
- Acquisition Scale: SiTime announced a deal to acquire timing assets from Renesas for up to $3.2 billion, with shares rising 17.9% on the first trading day post-announcement, indicating strong market confidence and potential for significant valuation increase.
- Revenue Growth Expectations: SiTime anticipates that the Renesas assets will generate $300 million in revenue in the first year post-acquisition, nearly doubling its fiscal 2025 sales of $326.7 million, highlighting substantial future growth potential for the company.
- Technological Integration Benefits: The deal will bring Renesas CEO Hidetoshi Shibata onto SiTime's board and facilitate the integration of SiTime's resonator technology into Renesas chips, which is more stable under temperature variations, making it suitable for the automotive chip market.
- Market Outlook: SiTime CEO Rajesh Vashist noted that billions of chips could eventually adopt this new technology, suggesting that while immediate revenue impact may be limited, the long-term prospects for market share and competitive advantage are significant.
- U.S. Stock Weakness: Midway through trading on Thursday, U.S. stocks declined significantly, with the Dow Jones dropping over 400 points, a 0.86% decrease to 49,073.13, indicating investor concerns about the economic outlook.
- Sector Performance Divergence: While real estate shares gained slightly by 0.1%, materials stocks fell by 2.2%, reflecting varying investor confidence across sectors, which could influence future investment strategies.
- Bristol Myers Earnings Beat: Bristol Myers Squibb reported fourth-quarter 2025 revenues of $12.50 billion, surpassing the consensus estimate of $12.281 billion with a 1% year-over-year increase, demonstrating resilience in a competitive pharmaceutical market.
- Weak Employment Data: U.S. job openings fell by 386,000 to 6.542 million in December, below the market estimate of 7.2 million, while initial jobless claims rose by 22,000 to 231,000, indicating challenges in the economic recovery.










